UB Paderborn / Katalog / Suche / in CDI

Dihydrofolate reductase inhibitors as antibacterial agents

Biochemical pharmacology, 2006-03, Vol.71 (7), p.941-948

2006

Volltextzugriff (PDF)

A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011

Pharmaceuticals, 2013-11, Vol.6 (11), p.1335-1346

2013

Volltextzugriff (PDF)

Emergence of High Levels of Extended-Spectrum-β-Lactamase-Producing Gram-Negative Bacilli in the Asia-Pacific Region: Data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program, 2007

Antimicrobial Agents and Chemotherapy, 2009-08, Vol.53 (8), p.3280-3284

2009

Volltextzugriff (PDF)

Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical gram-negative isolates from Czech Republic, Hungary, and Poland—SMART 2017–2020

European journal of clinical microbiology & infectious diseases, 2023-03, Vol.42 (3), p.365-370

2023

Volltextzugriff (PDF)

Antimicrobial Susceptibility of Inpatient Urinary Tract Isolates of Gram-Negative Bacilli in the United States: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program: 2009−2011

Clinical therapeutics, 2013-06, Vol.35 (6), p.872-877

2013

Volltextzugriff (PDF)

In vitro activity of imipenem/relebactam against Gram-negative ESKAPE pathogens isolated in 17 European countries: 2015 SMART surveillance programme

Journal of antimicrobial chemotherapy, 2018-07, Vol.73 (7), p.1872-1879

2018

Volltextzugriff (PDF)

Third-generation cephalosporin resistance in clinical isolates of Enterobacterales collected between 2016–2018 from USA and Europe: genotypic analysis of β-lactamases and comparative in vitro activity of cefepime/enmetazobactam

Journal of global antimicrobial resistance., 2021-06, Vol.25, p.93-101

2021

Volltextzugriff (PDF)

In vitro activity of ceftolozane/tazobactam against multidrug-resistant Pseudomonas aeruginosa from patients in Western Europe: SMART 2017-2020

International journal of antimicrobial agents, 2023-05, Vol.61 (5), p.106772-106772, Article 106772

2023

Volltextzugriff (PDF)

Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in Greece and Italy—SMART 2017–2021

European journal of clinical microbiology & infectious diseases, 2024-07, Vol.43 (7), p.1343-1348

2024

Volltextzugriff (PDF)

In vitro activity of eravacycline and comparators against Gram-negative and Gram-positive bacterial isolates collected from patients globally between 2017 and 2020

Journal of global antimicrobial resistance., 2023-06, Vol.33, p.304-320

2023

Volltextzugriff (PDF)

Incidence and Antimicrobial Susceptibility of Escherichia coli and Klebsiella pneumoniae with Extended-Spectrum β-Lactamases in Community- and Hospital-Associated Intra-Abdominal Infections in Europe: Results of the 2008 Study for Monitoring Antimicrobial Resistance Trends (SMART)

Antimicrobial Agents and Chemotherapy, 2010-07, Vol.54 (7), p.3043-3046

2010

Volltextzugriff (PDF)

In vitro activity of imipenem/relebactam against piperacillin/tazobactam-resistant and meropenem-resistant non- Morganellaceae Enterobacterales and Pseudomonas aeruginosa collected from patients with bloodstream, intra-abdominal and urinary tract infections in Western Europe: SMART 2018-2020

Journal of medical microbiology, 2023-02, Vol.72 (2)

2023

Volltextzugriff (PDF)

Using Nucleic Acid Microarrays To Perform Molecular Epidemiology and Detect Novel β-Lactamases: a Snapshot of Extended-Spectrum β-Lactamases throughout the World

Journal of Clinical Microbiology, 2012-05, Vol.50 (5), p.1632-1639

2012

Volltextzugriff (PDF)

Engineered peptide PLG0206 overcomes limitations of a challenging antimicrobial drug class

PloS one, 2022-09, Vol.17 (9), p.e0274815-e0274815

2022

Volltextzugriff (PDF)

Susceptibility of ceftobiprole against Gram-positive and Gram-negative clinical isolates from 2019 from different European territories

Journal of global antimicrobial resistance., 2022-06, Vol.29, p.393-397

2022

Volltextzugriff (PDF)

Surveillance of the activity of solithromycin (CEM-101) against bacteria from respiratory tract infections

International journal of antimicrobial agents, 2017-07, Vol.50 (1), p.17-22

2017

Volltextzugriff (PDF)

Susceptibility of Klebsiella pneumoniae Isolates from Intra-Abdominal Infections and Molecular Characterization of Ertapenem-Resistant Isolates

Antimicrobial Agents and Chemotherapy, 2011-08, Vol.55 (8), p.3917-3921

2011

Volltextzugriff (PDF)

Surveillance of ceftobiprole against Gram-positive and Gram-negative clinical isolates from 2018 from different European territories

Journal of global antimicrobial resistance., 2021-09, Vol.26, p.326-329

2021

Volltextzugriff (PDF)

Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004–2009

International journal of antimicrobial agents, 2011-03, Vol.37 (3), p.219-224

2011

Volltextzugriff (PDF)

Evaluation of the activity of cefepime/enmetazobactam against Enterobacterales bacteria collected in Europe from 2019 to 2021, including third-generation cephalosporin-resistant isolates

Journal of global antimicrobial resistance., 2024-09, Vol.38, p.71-82

2024

Volltextzugriff (PDF)

Activity of tigecycline against recent European clinical isolates of Clostridium difficile

International journal of antimicrobial agents, 2010-01, Vol.35 (1), p.97-98

Hawser, Stephen P

2010

Volltextzugriff (PDF)

Susceptibility of Gram-Negative Pathogens Isolated from Patients with Complicated Intra-Abdominal Infections in the United States, 2007-2008: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART)

Antimicrobial Agents and Chemotherapy, 2010-07, Vol.54 (7), p.3031-3034

2010

Volltextzugriff (PDF)

Etiology, Extended-spectrum β-lactamase Rates and Antimicrobial Susceptibility of Gram-negative Bacilli Causing Intra-abdominal Infections in Patients in General Pediatric and Pediatric Intensive Care Units-Global Data From The Study for Monitoring Antimicrobial Resistance Trends 2008 to 2010

The Pediatric infectious disease journal, 2013-06, Vol.32 (6), p.636-640

2013

Volltextzugriff (PDF)

Susceptibility of Klebsiella pneumoniae clinical isolates from 2007 to 2009 to colistin and comparator antibiotics

International journal of antimicrobial agents, 2010-10, Vol.36 (4), p.383-384

Hawser, Stephen P

2010

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Dihydrofolate reductase inhibitors as antibacterial agents

A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011

Emergence of High Levels of Extended-Spectrum-β-Lactamase-Producing Gram-Negative Bacilli in the Asia-Pacific Region: Data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program, 2007

Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical gram-negative isolates from Czech Republic, Hungary, and Poland—SMART 2017–2020

Antimicrobial Susceptibility of Inpatient Urinary Tract Isolates of Gram-Negative Bacilli in the United States: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program: 2009−2011

Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics

In vitro activity of imipenem/relebactam against Gram-negative ESKAPE pathogens isolated in 17 European countries: 2015 SMART surveillance programme

Third-generation cephalosporin resistance in clinical isolates of Enterobacterales collected between 2016–2018 from USA and Europe: genotypic analysis of β-lactamases and comparative in vitro activity of cefepime/enmetazobactam

In vitro activity of ceftolozane/tazobactam against multidrug-resistant Pseudomonas aeruginosa from patients in Western Europe: SMART 2017-2020

Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in Greece and Italy—SMART 2017–2021

In vitro activity of eravacycline and comparators against Gram-negative and Gram-positive bacterial isolates collected from patients globally between 2017 and 2020

Incidence and Antimicrobial Susceptibility of Escherichia coli and Klebsiella pneumoniae with Extended-Spectrum β-Lactamases in Community- and Hospital-Associated Intra-Abdominal Infections in Europe: Results of the 2008 Study for Monitoring Antimicrobial Resistance Trends (SMART)

In vitro activity of imipenem/relebactam against piperacillin/tazobactam-resistant and meropenem-resistant non- Morganellaceae Enterobacterales and Pseudomonas aeruginosa collected from patients with bloodstream, intra-abdominal and urinary tract infections in Western Europe: SMART 2018-2020

Using Nucleic Acid Microarrays To Perform Molecular Epidemiology and Detect Novel β-Lactamases: a Snapshot of Extended-Spectrum β-Lactamases throughout the World

Engineered peptide PLG0206 overcomes limitations of a challenging antimicrobial drug class

Susceptibility of ceftobiprole against Gram-positive and Gram-negative clinical isolates from 2019 from different European territories

Surveillance of the activity of solithromycin (CEM-101) against bacteria from respiratory tract infections

Susceptibility of Klebsiella pneumoniae Isolates from Intra-Abdominal Infections and Molecular Characterization of Ertapenem-Resistant Isolates

Surveillance of ceftobiprole against Gram-positive and Gram-negative clinical isolates from 2018 from different European territories

Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004–2009

Evaluation of the activity of cefepime/enmetazobactam against Enterobacterales bacteria collected in Europe from 2019 to 2021, including third-generation cephalosporin-resistant isolates

Activity of tigecycline against recent European clinical isolates of Clostridium difficile

Susceptibility of Gram-Negative Pathogens Isolated from Patients with Complicated Intra-Abdominal Infections in the United States, 2007-2008: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART)

Etiology, Extended-spectrum β-lactamase Rates and Antimicrobial Susceptibility of Gram-negative Bacilli Causing Intra-abdominal Infections in Patients in General Pediatric and Pediatric Intensive Care Units-Global Data From The Study for Monitoring Antimicrobial Resistance Trends 2008 to 2010

Susceptibility of Klebsiella pneumoniae clinical isolates from 2007 to 2009 to colistin and comparator antibiotics

Suchergebnisse filtern